Integrated-Protection-Technologies near St. Clements MB (507 Result(s))

Wound Biofilm© MSU-CBE, all rights reservedKane Biotech Inc. is dedicated to the research and development of products to prevent and disperse microbial biofilms. The Company was formed in 2001 and is developing products for the prevention and dispersal of biofilms focused on the genetic mechanisms of biofilm formation, and originally based upon the discovery of over 60 novel anti-biofilm targets. Kane Biotech Inc. uses a patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. The Company has evidence that this technology has potential to significantly improve the ability to prevent and/or destroy biofilms in several medical and industrial applications.Biofilms are estimated to be responsible for 80% of all human infections and cost industry, cities and hospitals in excess of $500 billion each year.Kane Biotech has a growing pipeline of products based on the Company's ability to screen for factors affecting biofilm formation and has resulted in the development of candidate products based on the demand for safe and effective anti-biofilm compounds.VisionTo become a global leader in creating innovative technology to breakdown and disperse biofilms and to develop unique products that have a positive impact on human health

At The First Glance Aesthetic Clinic & Surgery Centre, you have access to Award-Winning Board Certified Plastic Surgeons, Expert Nurse Injectors, Certified Laser Technicians, Skin Health Experts, Hair Transplant Specialists, Board Certified Gynecologists, Nurse Practitioners, and Professional Patient Coordinators all under one roof. Our expert Medical Aesthetics team have been serving patients across Canada for 25+ years. Voted Top Plastic Surgery Centre for 2023, 2022, and 2021. We also won the Canada-Wide Brilliant Distinctions Top Performer Award. The First Glance is a Top-Rated, Fully Accredited Medical Aesthetic Clinic & Surgery Centre. You will enjoy a fully privatized experience from beginning to end at our facility.

We are a Winnipeg Web Design & Digital Marketing Agency that provides full-stack website design, development, hosting, domain registration, website builder and digital marketing services. We specialize in WordPress and Shopify development and provide on-going webmaster support to marketing teams and agencies.

Free Network Health Assessment ($1500 Value)A FREE second look at your valuable IT network.This 30 Minute FREE assessment will reveal:Are your IT Systems truly secured from hackers, viruses, and rogue employees?Are your backups configured properly to ensure that you could be back up and running again fast in a disaster?Could you utilize cheaper and more efficient cloud computing technologies to lower IT costs?Are your systems optimized for maximum speed and performance?Sign me up to receive Constant C's latest updates, special offers, and more.YesNoPlease type the letters above into the field below.'Signing on with Constant C was one of the easiest business decisions I have ever made. One of their solutions is saving us over $12,000.00 per year. I highly recommend their services.

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.